Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schoemaker

Showing results (261-270 of 360) with videos related to

Pageof 36
Sort By:
Plos One|November 14, 2017
The composition and initial evaluation of a grimace scale in ferrets after surgical implantation of a telemetry probeMarsinah L Reijgwart, Nico J Schoemaker, Riccardo Pascuzzo, et al.
Breast Cancer Research : BCR|February 16, 2021
Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestryParichoy Pal Choudhury, Mark N Brook, Amber N Hurson, et al.
Journal of Neuro-Oncology|March 12, 2008
XRCC1 and XRCC3 variants and risk of glioma and meningiomaAnne Kiuru, Carita Lindholm, Sirpa Heinävaara, et al.
International Journal of Cancer|May 16, 2023
Cancer incidence and mortality in 23 000 patients with type 1 diabetes in the UK: Long-term follow-upAnthony J Swerdlow, Michael E Jones, Stefan D Slater, et al.
Journal of the National Cancer Institute|June 6, 2019
Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk StratificationParichoy Pal Choudhury, Amber N Wilcox, Mark N Brook, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumorsJudith A Schwartzbaum, Anders Ahlbom, Stefan Lönn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma riskJudith A Schwartzbaum, Anders Ahlbom, Stefan Lönn, et al.
BMC Pulmonary Medicine|May 27, 2025
Real-world treatment patterns and outcomes for patients with non-metastatic non-small cell lung cancer: retrospective analyses in Canada, England, and GermanyAlastair Greystoke, Melinda J Daumont, Caroline Rault, et al.
Journal of Neuro-Oncology|December 8, 2006
Genetic variation in p53 and ATM haplotypes and risk of glioma and meningiomaBeatrice Susanne Malmer, Maria Feychting, Stefan Lönn, et al.
Frontiers in Oncology|March 7, 2025
Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysisGrégoire Justeau, Christos Chouaid, Didier Debieuvre, et al.
Pageof 36

Showing results (261-270 of 360) with videos related to

Sort By:
Pageof 36
Plos One|November 14, 2017
The composition and initial evaluation of a grimace scale in ferrets after surgical implantation of a telemetry probeMarsinah L Reijgwart, Nico J Schoemaker, Riccardo Pascuzzo, et al.
Breast Cancer Research : BCR|February 16, 2021
Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestryParichoy Pal Choudhury, Mark N Brook, Amber N Hurson, et al.
Journal of Neuro-Oncology|March 12, 2008
XRCC1 and XRCC3 variants and risk of glioma and meningiomaAnne Kiuru, Carita Lindholm, Sirpa Heinävaara, et al.
International Journal of Cancer|May 16, 2023
Cancer incidence and mortality in 23 000 patients with type 1 diabetes in the UK: Long-term follow-upAnthony J Swerdlow, Michael E Jones, Stefan D Slater, et al.
Journal of the National Cancer Institute|June 6, 2019
Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk StratificationParichoy Pal Choudhury, Amber N Wilcox, Mark N Brook, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumorsJudith A Schwartzbaum, Anders Ahlbom, Stefan Lönn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma riskJudith A Schwartzbaum, Anders Ahlbom, Stefan Lönn, et al.
BMC Pulmonary Medicine|May 27, 2025
Real-world treatment patterns and outcomes for patients with non-metastatic non-small cell lung cancer: retrospective analyses in Canada, England, and GermanyAlastair Greystoke, Melinda J Daumont, Caroline Rault, et al.
Journal of Neuro-Oncology|December 8, 2006
Genetic variation in p53 and ATM haplotypes and risk of glioma and meningiomaBeatrice Susanne Malmer, Maria Feychting, Stefan Lönn, et al.
Frontiers in Oncology|March 7, 2025
Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysisGrégoire Justeau, Christos Chouaid, Didier Debieuvre, et al.
Pageof 36